Freestone Grove Partners’s Diebold Nixdorf DBD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$704K Buy
8,275
+1,459
+21% +$117K ﹤0.01% 593
2026
Q1
$514K Buy
+6,816
New +$502K ﹤0.01% 591
2025
Q4
Sell
-6,040
Closed -$344K 776
2025
Q3
$344K Buy
+6,040
New +$358K ﹤0.01% 591

Other funds holding DBD

Freestone Grove Partners's DBD Position: Q2 2026 in Review

Freestone Grove Partners increased its Diebold Nixdorf (DBD) stake by 21% in Q2 2026, buying an estimated $117K and bringing the position to 8,275 shares worth $704K. The position accounts for ﹤0.01% of the portfolio, ranked #593.

Freestone Grove Partners first reported a position in DBD in Q3 2025 and has held it in 3 quarters since. 216 funds tracked by Wall St. Rank hold DBD as of Q2 2026.

  • Freestone Grove Partners held 8,275 shares of Diebold Nixdorf worth $704K as of Q2 2026.
  • Freestone Grove Partners bought 1,459 Diebold Nixdorf shares in Q2 2026, an estimated $117K.
  • Diebold Nixdorf made up ﹤0.01% of Freestone Grove Partners's portfolio in Q2 2026, its #593 holding.
  • Freestone Grove Partners first reported a position in Diebold Nixdorf in Q3 2025 and has held it in 3 quarters since.
  • 216 funds tracked by Wall St. Rank held Diebold Nixdorf as of Q2 2026.

Based on Freestone Grove Partners's 13F filing for Q2 2026, filed 14 Aug 2026.